Latest news
Takeda Pharmaceutical (TAK) holder Elaine Shannon plans sale of 20,363 ADSs - Stock TitanStock Titan · Mon, 10 Aug 2026 20:31:05 GMTPhysician Views Preview: Orzeyful arrives — Will Takeda's drug redefine narcolepsy treatment? - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 16:47:18 GMTSpotlight On: Takeda breaks new ground with narcolepsy approval as Alkermes and Eli Lilly wait in slipstream - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 15:27:17 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - STATSTAT · Mon, 10 Aug 2026 11:33:33 GMTSilence brings the noise to Takeda with phase 2 blood cancer win - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:31:00 GMTShould FDA Approval of ORZEYFUL for Narcolepsy Type 1 Prompt Action From Takeda Pharmaceutical (TSE:4502) Investors? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 11:46:03 GMTAPAC Healthcare Weekly (August 9) – Hengrui, CSPC Pharma, Takeda Pharma, Otsuka, Alteogen - SmartkarmaSmartkarma · Sat, 08 Aug 2026 07:00:00 GMTFDA approves Takeda’s first-in-class narcolepsy drug - EMJEMJ · Fri, 07 Aug 2026 15:12:52 GMT